SLC22A15: A Potential Drug Target and Biomarker (G55356)

Target Name: SLC22A15

NCBI ID: G55356

SLC22A15

SLC22A15: A Potential Drug Target and Biomarker

SLC22A15 is a member of the SLC22 family, which is known as the solute carrier family 22. This family is responsible for the transport of a variety of molecules, including organic cations, across cell membranes. SLC22A15 is a cation transporter, which means it transports positively charged ions, such as sodium ions, across cell membranes.

SLC22A15 has been identified as a potential drug target due to its involvement in the regulation of ion homeostasis in the body. Disruptions in SLC22A15 function have been linked to a variety of diseases, including hypertension, heart failure, and neurodegenerative disorders. Additionally, SLC22A15 has also been shown to be involved in the regulation of pain perception and neurotransmitter release, which could make it a useful target for the treatment of pain conditions.

SLC22A15 has also been identified as a potential biomarker for a variety of diseases. For example, levels of SLC22A15 have been shown to be elevated in the blood of individuals with hypertension, which could be used as a diagnostic marker for this condition. Additionally, SLC22A15 levels have also been shown to be elevated in the blood of individuals with heart failure, which could be used as a diagnostic marker for this condition.

SLC22A15 is also a potential target for drug development due to its involvement in the regulation of ion homeostasis. Drugs that target SLC22A15 have the potential to treat a variety of conditions, including hypertension, heart failure, and neurodegenerative disorders. Additionally, SLC22A15 has also been shown to be involved in the regulation of pain perception and neurotransmitter release, which could make it a useful target for the treatment of pain conditions.

In conclusion, SLC22A15 is a promising drug target due to its involvement in the regulation of ion homeostasis and its potential as a biomarker for a variety of diseases. Further research is needed to fully understand the role of SLC22A15 in the regulation of ion homeostasis and its potential as a drug target and biomarker.

Protein Name: Solute Carrier Family 22 Member 15

Functions: Probably transports organic cations (By similarity). Appears not to be the agmatine transporter

The "SLC22A15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC22A15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets